20
Views
10
CrossRef citations to date
0
Altmetric
Original Article

Randomized Study of Sulfamethoxazole-trimethoprim versus Aerosolized Pentamidine for Secondary Prophylaxis of Pneumocystis carinii Pneumonia in Patients with AIDS

, , , , &
Pages 217-220 | Received 27 Oct 1994, Accepted 22 Jan 1995, Published online: 08 Jul 2009

References

  • Kovacs J. A., Masur H. Pneumocystis carinii pneumonia: Therapy and prophylaxis. J Infect Dis 1988; 158: 254–259
  • Smith E., Orholm M. Trends and patterns of opportunistic diseases in Danish Aids patients, 1980–1990. Scand J Infect Dis 1990; 22: 665–672
  • Kovacs J. A., Masur H. Prophylaxis for pneumocystis carinii pneumonia in patients infected with human immunodeficiency virus. Clin Infect Dis 1992; 14: 1005–1009
  • Nielsen T. L., Schattenkerk J. KME, Jensen B. N., Lundgren J. D., Gerstoft J., Steenwijk R. P., Bentsen K., Frissen P. HJ, Gaub J., Orholm M., Hansen J. E., Mathiesen L., Skinhøj P., Danner S. A., Nielsen J. O. Adjunctive corticosteroid therapy for pneumocystis carinii pneumonia in AIDS. A randomized European multicenter open label study. J Acquir Immune Defic Syndr 1992; 5: 726–731
  • Hardy D., Feinberg J., Finkelstein D., Power M., He W., Kaczka C., Frame P., Holmes M., Waskin H., Fass R., Powderly W., Steigbigel R., Zuger A., Holtzman R. A Controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. N Engl J Med 1992; 327: 1842–1848
  • Schneider M. ME, Hoepelman A. IH, Schattenkerk J. KME, Nielsen T. L., Graff Y., Frissen J., Ende I. ME, Kolsters A. Borleffs JCC and the Dutch AIDS Treatment Group. A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. N Engl J Med 1992; 327: 1836–1841
  • Mallolas J., Zamora L., Gatell J. M., Miró J. M., Vernet E., Valls M. E., Soriano E., San Miguel J. G. Primary prophylaxis for pneumocystis carinii pneumonia: a randomized trial comparing cotrimoxazole, aerosolized pentamidine and dapsone plus pyrimethamine. AIDS 1993; 7: 59–64
  • May T., Beuscart J., Reynes B., Marchou B., Leclercq P., Lebas B., Saba J., Micoud M., Mouton M., Canton Ph. Trimethoprim-sulfamethoxazole versus aerosolized pentamidine for primary prophylaxis of pneumocystis carinii pneumonia: A prospective, randomized, controlled trial. J Acquir Immune Defie Syndrome 1994; 457–462
  • Jakobson M. A., Besch C. L., Child C., Hafner R., Matis J. P., Muth K., Wentworth D. N., Neaton J. D., Abrams D., Rimland D., Perez G., Grant I. H., Saravoaltz L. D., Brown L. S., Deyton L. Primary prophylaxis with pyrimethamine for toxoplasmic encaphalitis in patients with advanced human immunodeficiency virus disease: Results of a randomized trial. J Infect Dis 1994; 169: 384–394
  • Schneider M. ME, Nielsen T. L., Hoepelman A. IM, Nelsing S., Graaf Y., Kolsters A. FP, Borleffs J. CC. Two doses of trimethoprim-sulfamethoxazole as primary prophylaxis against pneumocystis carinii pneumonia in HIV-infected patients. 33nd ICAAC New Orleans M097, 1993
  • Shafer R. W., Seitzman P. A., Tapper M. L. Successful prophylaxis of Pneumocystis carinii pneumonia with trimethoprim-sulfamethoxazole in AIDS patients with previous allergic reactions. J Acquir Immune Defic Syndr 1989; 2: 389–393
  • Center for Disease Control. Guidelines for prophylaxis against Pneumocystis carinii pneumonia for persons infected with human immunodeficiency virus. MMWR 1989; 38: 1–9
  • Center for Disease Control. Recommendations for prophylaxis against Pneumocystis carinii pneumonia for adults and adolescents infected with human immunodeficiency virus. MMWR 1992; 41: 1–11
  • Nielsen T. L., Jensen B. N., Nelsing S., Pedersen C., Mathiesen L. R., Skinhøj P., Nielsen J. O. Prevention of pneumocystis carinii pneumonia relapse in AIDS patients. Dan Med Bull 1993; 40: 503–505
  • Carr A., Tindall B., Penny R., Cooper D. A. Trimethoprim-sulfamethoxazole appears more effective than aerosolized pentamidine as secondary prophylaxis against pneumocystis carinii pneumonia in patients with AIDS. AIDS 1992; 6: 165–171
  • Raviglione M. C., Nash E. N., Cortes H., Mariuz P., Sanjana Veeraf. Intermittent co-trimoxazole prophylaxis against Pneumocystis carinii pneumonia. Lancet 1990; 336: 180
  • Ruskin J., Laviriere M. Low-dose cotrimoxazole for prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus disease. Lancet 1991; 468–471
  • Hirschel B., Lazzaran A., Chopard P., Opravil M., Furrer H. J., Ruttimann S., Vernazza P., Chave J. P., Acarani F., Gabriel V., Heald A., Nicod L., Loredana S., Vivirito M. C., Zerboni R., Swiss group for clinical studies on AIDS. A controlled study of inhaled pentamidine for primary prevention of Pneumocystis carinii pneumonia. N Engl J Med 1991; 324: 1079–1083, and the
  • Leoung G. S., Feigal D. W., Montgomery B., Corkery K., Wardlaw L., Adams M., Busch D., Gordon S., Jacobseon M. A., Volberding P., Abrams D. Aerosolized pentamidine for prophylaxis against Pneumocystis carinii pneumonia. N Engl J Med 1990; 323: 769–775
  • Jensen B. N., Nielsen T. L., Backer V., Nelsing S., Simonsen L., Flaschs H., Gaub J., Højlyng N., Nielsen J. O., Mathiesen L., Skinhøj P. Aerosolized pentamidine for primary prophylaxis of Pneumocystis carinii pneumonia: A controlled, randomized trial. J Acquir Immune Defic Syndr 1993; 6: 472–477

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.